淀粉样蛋白PET定量与Centiloid阈值在阿尔茨海默病诊断中的个体参与者数据Meta分析
数据驱动方法得出单阈值18 Centiloid,双阈值法显示低于11可高置信度判阴性、高于26可判阳性,与视觉读片对应最佳阈值为27 Centiloid。
要点
- 数据驱动阳性阈值为18 Centiloid(95%CI 16-19)。
- 双阈值法:低于11判阴性,高于26判阳性,11-26区间需谨慎解读。
- 与视觉读片对应最佳阈值为27 Centiloid(95%CI 24-30)。
核心结论
- 淀粉样蛋白PET的Centiloid阳性阈值在数据驱动方法下收敛于18,与视觉读片对应阈值收敛于27。
- 双阈值分析提示11至26 Centiloid区间的扫描结果应结合使用场景谨慎解读。
研究设计与样本
- 参与者平均年龄71岁,54%为女性,62%存在认知障碍。
- 采用统一统计流程分析每项研究,研究估计值通过随机效应Meta分析合并。
主要发现
- 双阈值法显示Centiloid低于11(95%CI 9-13;I2=95%)时高置信度判为阴性,高于26(95%CI 24-28;I2=95%)时判为阳性。
关键数值与推荐
- 数据驱动单阳性阈值:18 Centiloid(95%CI 16-19;I2=97%)。
- 双阈值法阴性高置信区间:低于11 Centiloid(95%CI 9-13;I2=95%)。
- 双阈值法阳性高置信区间:高于26 Centiloid(95%CI 24-28;I2=95%)。
- 与视觉读片对应最佳阈值:27 Centiloid(95%CI 24-30;I2=80%)。
临床怎么用
- 临床解读淀粉样蛋白PET的Centiloid值时,可将18作为数据驱动的阳性参考阈值。
- Centiloid值低于11可高置信度判为淀粉样蛋白阴性,高于26可高置信度判为阳性。
- Centiloid值在11至26之间时,应结合具体临床场景谨慎解读,避免仅凭单一阈值决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Amyloid positron emission tomography (PET) is increasingly used in research and clinical settings to determine the etiology of cognitive decline and eligibility for amyloid-targeting therapies. To assist with amyloid PET evaluation and to guide clinical decision-making, images can be quantified in a standardized unit called Centiloid, the interpretation of which can vary according to the method and threshold used. OBJECTIVE: To collect Centiloid values from available studies and determine robust positivity cutoffs using data-driven methods and correspondence with visual reads. DATA SOURCES: PubMed search (October 2024) identified studies with Centiloid values. Corresponding authors were invited to share individual participant data. Additional data were obtained through access-controlled repositories and conference outreach (July 2024-July 2025). STUDY SELECTION: Studies were included if they provided Centiloids, radiotracer, age, and sex. DATA EXTRACTION AND SYNTHESIS: Each study was analyzed using a unified statistical pipeline; study estimates were pooled using random-effects meta-analysis. MAIN OUTCOMES AND MEASURES: Gaussian mixture models (GMMs) were fitted to Centiloid values for each study. In studies with a bimodal distribution (per integrated completed likelihood), single cutoffs for positivity were set as mean plus 2 SDs of the lower gaussian component. Using GMMs, a double-cutoff approach defined a lower certainty range using a 90% posterior probability cutoff for assignment to the low (amyloid-negative) vs high (amyloid-positive) component. An alternative Centiloid cutoff was derived from maximizing the correspondence (Cohen κ) with the binary visual reads when available. RESULTS: This meta-analysis included cross-sectional amyloid PET scans acquired with 5 radiotracers from 49 227 participants across 53 studies from 15 countries (mean age, 71 years; 54% female, 62% cognitively impaired). The data-driven GMM approach identified a bimodal distribution in 51 studies (n = 48 786), resulting in a single cutoff for positivity of 18 Centiloids (95% CI,16-19; I2 = 97%). The double-cutoff approach revealed high confidence for interpreting scans as negative when Centiloid values were lower than 11 (95% CI, 9-13; I2 = 95%) and interpreting scans as positive if Centiloid values were higher than 26 (95% CI, 24-28; I2 = 95%). In analyses of correspondence with binary (positive or negative) visual reads of amyloid PET scans (n = 35 045; 36 studies), Centiloids were highly predictive of visual positivity (Cohen κ, 0.86; 95% CI, 0.83-0.89; I2 = 96%) with a cutoff of 27 Centiloids (95% CI, 24-30; I2 = 80%). CONCLUSIONS AND RELEVANCE: In this individual participant data meta-analysis, positivity cutoffs converged around 18 Centiloids (data-driven) and 27 Centiloids (visual reads). Findings from a double-cutoff analysis suggest that scans in the 11 to 26 Centiloid range should be interpreted with caution depending on the context of use.
引用
- Blazhenets G, Soleimani-Meigooni DN, Chiotis K, et al. Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis. JAMA. 2026. PMID: 42441390. doi:10.1001/jama.2026.13116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。